Pawel Grzywacz

This inventor holds 38 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Vitamin D Analogs. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2004-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pawel Grzywacz. Retrieved from https://idiyas.com/inventor/pawel-grzywacz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 4)

% Patents Active = 44.7

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 4.0

ph-index = 9

Forward Citations = 1,225(Granted Patents)

Company Filing History:

38 out of 4,238

Wisconsin Alumni Research Foundation

patents

Years Active: 2004-2015

Loading Chart...

Areas of Expertise:

Vitamin D Analog

Synthesis

Ligands

Ah Receptor

Hydroxyvitamin D

Dinor Compounds

Trinor Compounds

Methylated Forms

Crystalline Form

Indole Thiazole

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9212137 - [object Object] (2015-12-15),

2. 8664206 - [object Object] (2014-03-04),

3. 8614202 - [object Object] (2013-12-24),

4. 8609643 - 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs (2013-12-17),

5. 8604009 - [object Object] (2013-12-10),

6. 8445468 - [object Object] (2013-05-21),

7. 8440647 - [object Object] (2013-05-14),

8. 8404874 - [object Object] (2013-03-26),

9. 8404666 - 2-substituted-1α,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof (2013-03-26),

10. 8399439 - 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs (2013-03-19),

11. 8193171 - [object Object] (2012-06-05),

12. 8193170 - 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs (2012-06-05),

13. 8193169 - (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs (2012-06-05),

14. 8114859 - 2-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogs (2012-02-14),

15. 8030295 - [object Object] (2011-10-04),

Title: Pawel Grzywacz: Innovator in Pharmaceutical Compounds

Introduction

Pawel Grzywacz, based in Madison, WI, is a prominent inventor known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 38 patents, he has dedicated his career to developing innovative methods and compounds that have the potential to improve healthcare outcomes.

Latest Patents

Among his latest inventions, Grzywacz has disclosed methods of purifying the compound (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D to achieve its crystalline form. These methods involve dissolving the compound in a solvent composed of hexane and 2-propanol, followed by cooling to allow crystal formation. Additionally, Grzywacz has contributed compounds of formula I, which are useful in creating pharmaceutical compositions targeting various biological conditions.

Career Highlights

Grzywacz's career is marked by his association with the Wisconsin Alumni Research Foundation, where he has made notable advancements in chemical research and innovation. His extensive work in the field showcases his commitment to enhancing pharmaceutical developments through innovative approaches and methodologies.

Collaborations

Throughout his career, Pawel has collaborated with esteemed colleagues such as Hector Floyd DeLuca and Lori A. Plum. These partnerships have fostered a collaborative environment, driving forward research initiatives and furthering the understanding of complex pharmaceutical compounds.

Conclusion

Pawel Grzywacz stands out as a leading inventor whose work is shaping the future of pharmaceuticals. With his ongoing innovations and extensive research efforts, he continues to contribute valuable insights and solutions to the medical community, making significant strides in the realm of drug development.

Profile summary based on public USPTO records.